Objective(s): In this study, we aimed to describe the characteristics of portal vein tumor thrombosis (PVTT), complicating hepatocellular carcinoma (HCC) in contrast-enhanced FDG PET/CT scan. Methods: In this retrospective study, 9 HCC patients with FDG-avid PVTT were diagnosed by contrast-enhanced fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT), which is a comb...

Hepatocellular carcinoma (HCC) was the sixth most common cancer and third cause of cancer-related deaths worldwide in 2020. Liver resection transplantation remain cornerstone for patients with early-stage disease represent only option potential cure HCC. However, fewer than 10% are considered suitable surgery at time diagnosis. Locoregional therapies, defined as minimally invasive image-guided ...

Sorafenib is a breakthrough in the medical treatment aiming to control hepatocellular carcinoma (HCC) progression, but there some controversy patients' selection. The introduction of has led several positive effects. New more than promising antiangiogenic molecules have followed. Immunotherapy combined with therapy also strongly entered into HCC. All that induced significant guideline revision ...

Background: Hepatocellular carcinoma (HCC) is a major type of liver tumor. It represents up to 90% all malignancies. There are currently no reliable tumor markers or imaging technologies that can accurately diagnose early HCC. The use circulating micro-RNAs (miRNAs miR) as potential tool for detection HCC has become an emerging area study. Objectives: This study aimed evaluate the role miR-23b ...

According to the WHO’s recently released worldwide cancer data for 2020, liver ranks sixth in morbidity and third mortality among all malignancies. Hepatocellular carcinoma (HCC), most common kind of cancer, accounts approximately 80% primary malignancies is one leading causes death globally. The intractable tumor microenvironment plays an important role development progression HCC three major ...

IntroductionHepatocellular carcinoma (HCC) is the most common primary malignant tumor of liver.AimThis study aimed to assess serum hTERT level and its relation progression liver disease. Also, it effect HCV core protein on memory T-cells in patients with or without HCC, correlation between cells phenotype disease same patients.MethodsHTERT was assessed through relative quantitative RT-PCR. Flow...

Hepatocellular carcinoma (HCC) is a worldwide malignant tumor that caused irreversible consequences. Tanshinone IIA has been shown to play notable role in HCC treatment. However, the potential targets and associating mechanism of against remain unknown. We first screened out 105 overlapping genes by integrating predicted from multiple databases differentially expressed Cancer Genome Atlas (TCGA...